These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2440124

  • 1. Influence of factor XIIIa activity on human whole blood clot lysis in vitro.
    Jansen JW, Haverkate F, Koopman J, Nieuwenhuis HK, Kluft C, Boschman TA.
    Thromb Haemost; 1987 Apr 07; 57(2):171-5. PubMed ID: 2440124
    [Abstract] [Full Text] [Related]

  • 2. Cross-linking of alpha 2-antiplasmin to fibrin is a key factor in regulating blood clot lysis: species differences.
    van Giezen JJ, Minkema J, Bouma BN, Jansen JW.
    Blood Coagul Fibrinolysis; 1993 Dec 07; 4(6):869-75. PubMed ID: 7511944
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of concomitant thrombin-mediated fibrin formation enhances clot lysis in whole blood.
    Haskel EJ, Eisenberg PR, Abendschein DR.
    Blood Coagul Fibrinolysis; 1993 Feb 07; 4(1):7-13. PubMed ID: 8457655
    [Abstract] [Full Text] [Related]

  • 4. In vitro inhibition of factor XIII retards clot formation, reduces clot firmness, and increases fibrinolytic effects in whole blood.
    Jámbor C, Reul V, Schnider TW, Degiacomi P, Metzner H, Korte WC.
    Anesth Analg; 2009 Oct 07; 109(4):1023-8. PubMed ID: 19762725
    [Abstract] [Full Text] [Related]

  • 5. Platelet-associated factor XIII in platelet activation, adhesion, and clot stabilization.
    Devine DV, Bishop PD.
    Semin Thromb Hemost; 1996 Oct 07; 22(5):409-13. PubMed ID: 8989824
    [Abstract] [Full Text] [Related]

  • 6. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.
    Colucci M, D'Aprile AM, Italia A, Gresele P, Morser J, Semeraro N.
    Thromb Haemost; 2001 Apr 07; 85(4):661-6. PubMed ID: 11341502
    [Abstract] [Full Text] [Related]

  • 7. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr 07; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activation and lysis of blood clots induced by cells in vitro.
    Knox P, Crooks S.
    J Cell Physiol; 1988 Jun 07; 135(3):467-73. PubMed ID: 2456288
    [Abstract] [Full Text] [Related]

  • 9. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA, Booth NA, Croll AM, Bennett B.
    Thromb Haemost; 1993 Aug 02; 70(2):301-6. PubMed ID: 8236139
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL, Matsueda GR, Haber E.
    Thromb Haemost; 1992 Sep 07; 68(3):315-20. PubMed ID: 1279832
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG.
    Blood Coagul Fibrinolysis; 2010 Sep 07; 21(6):584-7. PubMed ID: 20683324
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.